Related Experiment Videos
Acute puerperal uterine inversion. New approaches to management
H S Brar1, J S Greenspoon, L D Platt
1Department of Obstetrics and Gynecology, University of Southern California School of Medicine, Los Angeles.
The Journal of Reproductive Medicine
|February 1, 1989
Summary
Uterine inversion risk factors include first birth, fundal placenta, and large babies. Oxytocin use increases puerperal inversion risk, while retained placenta may prevent shock. Betamimetics or MgSO4 aid uterine repositioning.
Area of Science:
- Obstetrics and Gynecology
- Reproductive Medicine
Background:
- Uterine inversion is a rare but serious obstetric emergency.
- Understanding risk factors and effective management is crucial for patient outcomes.
Purpose of the Study:
- To identify risk factors associated with uterine inversion.
- To evaluate management strategies and their effectiveness.
Main Methods:
- Retrospective review of 56 patients with uterine inversion (1977-1986).
- Data collected from obstetric statistics, delivery records, and discharge diagnoses.
- Analysis of patient demographics, delivery details, and interventions.
Main Results:
- Risk factors identified: primiparity, fundally implanted placenta, macrosomic fetus.
- Oxytocin use (with or without MgSO4) correlated with higher inversion risk.
- Attached placenta showed a protective effect against shock.
- Betamimetics or MgSO4 were effective alternatives to general anesthesia for uterine repositioning.
- Success rates were higher in acute vs. subacute and second-degree vs. third-degree inversions.
Conclusions:
- Primiparity, fundal placental implantation, and macrosomia are significant risk factors for uterine inversion.
- Oxytocin administration requires careful consideration due to increased risk.
- Betamimetics and MgSO4 offer viable therapeutic options for uterine repositioning, particularly in acute and less severe cases.